Friday, April 1, 2022

Scientific consortium provides real-time risk assessment of SARS-CoV-2 variants on immune protection

A new program has been set up to provide a real-time risk assessment of variants of SARS-CoV-2, the virus that causes COVID-19. The program assesses how the variants might affect transmission, virulence, and resistance to both disease-induced (convalescent) and vaccine-induced immunity.

from Top Health News -- ScienceDaily https://ift.tt/O4agSyV
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists reveal the real benefits and hidden risks of medical cannabis

A sweeping review of more than 2,500 studies reveals that despite booming public enthusiasm, cannabis has strong scientific support for only...